Press Releases & Author Interviews
-
New Aging Clock Predicts Early Risk of Muscle Loss in Older Adults
A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on June 9, 2025, titled “Developing a quantitative estimate of muscle age acceleration by a novel phenotypic clock: cross-sectional study in healthy, middle-aged and older adults.”
-
Behind the Study: Enhancing Oocyte Activation in Women with Ovarian Failure
Dr. Amparo Santamaria describes a her research paper, titled “Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the Stem Cell Regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice.” … continue reading
-
How Telomerase Inactivation in Aging Cells Influences Cancer Growth and Metastasis
A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on June 5, 2025, titled “Senescence caused by telomerase inactivation in myeloid, mesenchymal, and endothelial cells has distinct effects on cancer progression.” … continue reading
-
Spermidine and Protein Restriction Independently Protect Brain and Body from Aging in Flies
A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on June 7, 2025, titled “Spermidine supplementation and protein restriction protect from organismal and brain aging independently.” … continue reading
Aging: Volume 17, Issue 6
-
DoliClock: a lipid-based aging clock reveals accelerated aging in neurological disorders
This study introduces DoliClock, a lipid-based biological aging clock designed to predict the age of the prefrontal cortex using post-mortem lipidomic data. Significant age acceleration was observed in autism, schizophrenia, and Down syndrome.
Aging Blogs
ABOUT Dr. Mikhail (Misha) Blagosklonny:
It is with great sadness and heavy heart that we announce the recent passing of Dr. Mikhail (Misha) V. Blagosklonny, our beloved Editor-in-Chief. Misha succumbed to metastatic lung cancer after a courageous battle.
Dr. Blagosklonny will be remembered as a brilliant and extraordinary scientist who dedicated his life to science. He was a visionary thinker, who made highly original contributions to cancer and aging research that were often ahead of their time.
Dr. Blagosklonny was born into a family of scientists. His mother, Professor of Medicine Yanina V. Blagosklonnaya, specialized in endocrinology and was a talented teacher, mentoring several generations of medical students. His father, Professor Vladimir M. Dilman, was a brilliant gerontologist, endocrinologist and oncologist, known for being a very charismatic person. He was the first person to encourage Misha to think about nature, aging, and philosophy.
Misha was a theorist by nature. While in school, he was deeply interested in physics and dreamed of becoming a theoretical physicist. Eventually, he chose biology, driven to study aging and age-related diseases, including cancer. He started as an experimentalist, but over the years, he became a theoretical biologist. In a way, his dream came true.
In Remembrance | Call for Papers: Commemorative Collection Honoring Dr. Blagosklonny | @Blagosklonny
ABOUT AGING-US.NET
Aging-US.net features interviews and testimonials from the distinguished network of authors who continue to publish their research with Aging (Aging-US)—monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.
The mission of the journal is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease.
We aim to promote: 1) The development of preventative strategies that delay or mitigate age-associated pathologies by modulating key aging mechanisms, 2) the treatment of age-related diseases through interventions that target the aging process itself, and 3) the validation of anti-aging therapies by demonstrating their impact on functional decline and disease onset.
Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.
To learn more, please visit Aging-US.com and connect with us:
Facebook | X | LinkedIn | YouTube | Instagram | Bluesky | Pinterest | SoundCloud
